We are live on ! Find out more
MD icon

Pediatrix Medical

391 hedge funds and large institutions have $6.68B invested in Pediatrix Medical in 2016 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 148 increasing their positions, 133 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more call options, than puts

Call options by funds: $6.11M | Put options by funds: $2.55M

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

41% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 32

11% more repeat investments, than reductions

Existing positions increased: 148 | Existing positions reduced: 133

11% more capital invested

Capital invested by funds: $6.01B → $6.68B (+$667M)

2% more funds holding

Funds holding: 382391 (+9)

0.7% more ownership

Funds ownership: 98.62%99.32% (+0.7%)

Holders
391
Holders Change
+9
Holders Change %
+2.36%
% of All Funds
10.43%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
45
Increased
148
Reduced
133
Closed
32
Calls
$6.11M
Puts
$2.55M
Net Calls
+$3.55M
Net Calls Change
-$3.05M
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
226
Shell Asset Management
Netherlands
$1.04M +$354K +5,151 +56%
AAM
227
Azzad Asset Management
Virginia
$1.04M
AB
228
Amalgamated Bank
New York
$984K +$245K +3,558 +31%
Thrivent Financial for Lutherans
229
Thrivent Financial for Lutherans
Minnesota
$963K +$92.8K +1,350 +11%
Mitsubishi UFJ Asset Management
230
Mitsubishi UFJ Asset Management
Japan
$957K +$18.9K +275 +2%
PNC Financial Services Group
231
PNC Financial Services Group
Pennsylvania
$936K -$284K -4,135 -24%
MC
232
Montag & Caldwell
Georgia
$934K +$4.13K +60 +0.5%
PA
233
Profund Advisors
Maryland
$903K +$2.41K +35 +0.3%
SB
234
Suntrust Banks
Georgia
$884K -$171K -2,490 -17%
LRPA
235
L. Roy Papp & Associates
Arizona
$832K +$85.6K +1,245 +12%
SAM
236
Securian Asset Management
Minnesota
$816K -$94.8K -1,379 -11%
Barclays
237
Barclays
United Kingdom
$796K +$102K +1,488 +16%
NIMI
238
Natixis Investment Managers International
France
$795K +$755K +10,978 New
M&T Bank
239
M&T Bank
New York
$790K -$156K -2,266 -17%
ProShare Advisors
240
ProShare Advisors
Maryland
$790K -$9.14K -133 -1%
WB
241
WesBanco Bank
West Virginia
$789K -$419K -6,100 -36%
USAA
242
United Services Automobile Association
Texas
$781K +$11.7K +170 +2%
DCM
243
Driehaus Capital Management
Illinois
$779K -$167K -2,423 -18%
Nomura Asset Management
244
Nomura Asset Management
Japan
$765K
LS
245
Livforsakringsbolaget Skandia
Sweden
$761K
JMPWA
246
JP Morgan Private Wealth Advisors
California
$760K +$148K +2,147 +26%
WPC
247
White Pine Capital
Minnesota
$735K -$13.7K -200 -2%
Capstone Investment Advisors
248
Capstone Investment Advisors
New York
$721K +$684K +9,957 New
SOADOR
249
State of Alaska Department of Revenue
Alaska
$708K +$43.3K +630 +7%
SKK
250
Shepherd Kaplan Krochuk
Massachusetts
$706K

MD Hedge Fund Activity: Q2 2016 in Review

391 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2016, worth a combined $6.68B — up 11% from $6.01B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new MD positions and 32 closed out — a net gain of 13 holders — while 148 added to existing stakes and 133 trimmed.

The largest buyer was Nordea Investment Management, adding an estimated $147M. The largest seller was Bank of New York Mellon, cutting an estimated $81.8M.

  • 391 institutional investors held Pediatrix Medical (MD) as of Q2 2016, up from 382 in Q1 2016.
  • Funds reported $6.68B of Pediatrix Medical stock for Q2 2016, up 11% quarter-over-quarter.
  • 45 funds opened new Pediatrix Medical positions in Q2 2016 and 32 closed out, a net change of +13 holders.
  • The largest Pediatrix Medical buyer in Q2 2016 was Nordea Investment Management, an estimated $147M added.
  • The largest Pediatrix Medical seller in Q2 2016 was Bank of New York Mellon, an estimated $81.8M sold.

Based on aggregated 13F filings for Q2 2016.